최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Investigative and clinical urology, v.64 no.3, 2023년, pp.202 -
Kim, Kyung Hwan (Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.) , Lee, Hye Won (Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea.) , Ha, Hong Koo (Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.) , Seo, Ho Kyung (Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea.)
초록이 없습니다.
CA Cancer J Clin Sung 71 209 2021 10.3322/caac.21660
Eur Urol Burger 63 234 2013 10.1016/j.eururo.2012.07.033
J Clin Oncol Stein 19 666 2001 10.1200/JCO.2001.19.3.666
Cancer Prout 9 551 1956 10.1002/1097-0142(195605/06)9:3<551::AID-CNCR2820090319>3.0.CO;2-2
BJU Int Martini 125 270 2020 10.1111/bju.14872
Cancer Cahn 123 4337 2017 10.1002/cncr.30900
Eur Urol Advanced Bladder Cancer (ABC) Meta-analysis Collaboration 48 202 2005 10.1016/j.eururo.2005.04.006
Eur Urol Solsona 43 489 2003 10.1016/S0302-2838(03)00100-3
Can Urol Assoc J Cagiannos 3 6 Suppl 4 S237 2009
Eur Urol Rink 61 810 2012 10.1016/j.eururo.2012.01.017
Clin Cancer Res Kurahashi 11 3773 2005 10.1158/1078-0432.CCR-04-2297
Scand J Urol Nephrol Jensen 45 419 2011 10.3109/00365599.2011.599336
Eur Urol Focus Gakis 6 632 2020 10.1016/j.euf.2020.01.007
European Association of Urology. Muscle-invasive and metastatic bladder cancer [Internet]. Arnhem. EAU Guidelines Office. 2022. cited 2022 Oct 27. Available from: https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer
National Comprehensive Cancer Network. NCCN guidelines of patients®. Bladder cancer [Internet]. Plymouth Meeting. NCCN Foundation. 2021. cited 2022 Oct 27. Available from: https://www.nccn.org/patients/guidelines/content/PDF/bladder-patient.pdf
Eur Urol Sherif 45 297 2004 10.1016/j.eururo.2003.09.019
N Engl J Med Grossman 349 859 2003 10.1056/NEJMoa022148
Oncologist Yin 21 708 2016 10.1634/theoncologist.2015-0440
BJU Int Mitra 109 846 2012 10.1111/j.1464-410X.2011.10455.x
Nat Rev Urol Jiang 18 104 2021 10.1038/s41585-020-00404-6
J Clin Oncol Apolo 35 2117 2017 10.1200/JCO.2016.71.6795
Lancet Oncol Sharma 18 312 2017 10.1016/S1470-2045(17)30065-7
N Engl J Med Bellmunt 376 1015 2017 10.1056/NEJMoa1613683
Cancer Chemother Pharmacol D'Angelo 90 191 2022 10.1007/s00280-022-04459-7
J Clin Oncol Powles 39 6 Suppl TPS505 2021 10.1200/JCO.2021.39.6_suppl.TPS505
Future Oncol Sonpavde 16 4359 2020 10.2217/fon-2019-0611
J Clin Oncol International Collaboration of Trialists 29 2171 2011 10.1200/JCO.2010.32.3139
J Clin Oncol Choueiri 32 1889 2014 10.1200/JCO.2013.52.4785
J Urol Malmström 155 1903 1996 10.1016/S0022-5347(01)66042-7
Scand J Urol Nephrol Sherif 36 419 2002 10.1080/003655902762467567
J Clin Oncol Plimack 32 1895 2014 10.1200/JCO.2013.53.2465
J Clin Oncol von der Maase 23 4602 2005 10.1200/JCO.2005.07.757
J Clin Oncol von der Maase 18 3068 2000 10.1200/JCO.2000.18.17.3068
Cancer Dash 113 2471 2008 10.1002/cncr.23848
J Clin Oncol Iyer 36 1949 2018 10.1200/JCO.2017.75.0158
Oncology Niedersüss-Beke 93 36 2017 10.1159/000463389
Int Braz J Urol Herchenhorn 33 630 2007 10.1590/S1677-55382007000500004
Clin Cancer Res Flaig 27 2435 2021 10.1158/1078-0432.CCR-20-2409
J Clin Oncol Pfister 40 2013 2022 10.1200/JCO.21.02051
J Clin Oncol Galsky 29 2432 2011 10.1200/JCO.2011.34.8433
Eur J Clin Pharmacol Casanova 76 23 2020 10.1007/s00228-019-02771-5
J Urol deVere White 181 2476 2009 10.1016/j.juro.2009.01.115
JAMA Oncol Peyton 4 1535 2018 10.1001/jamaoncol.2018.3542
Oncol Lett Hussain 3 855 2012
Oncologist Osterman 24 688 2019 10.1634/theoncologist.2018-0561
Urology Narain 154 8 2021 10.1016/j.urology.2021.03.010
Eur Urol Oncol Boeri 2 390 2019 10.1016/j.euo.2018.09.004
Eur Urol Focus Motterle 6 642 2020 10.1016/j.euf.2019.10.016
Eur Urol Humphrey 70 106 2016 10.1016/j.eururo.2016.02.028
Clin Genitourin Cancer Pokuri 14 e59 2016 10.1016/j.clgc.2015.09.013
J Urol Hajiran 205 100 2021 10.1097/JU.0000000000001325
Expert Rev Anticancer Ther Jain 20 603 2020 10.1080/14737140.2020.1784011
Eur Urol Focus Daneshmand 6 639 2020 10.1016/j.euf.2020.04.011
J Urol Chakiryan 206 924 2021 10.1097/JU.0000000000001855
Clin Oncol (R Coll Radiol) Tulpule 33 e257 2021 10.1016/j.clon.2021.03.021
BJU Int Scosyrev 108 693 2011 10.1111/j.1464-410X.2011.10582.x
Future Oncol Kaimakliotis 12 1795 2016 10.2217/fon-2016-0056
Nat Rev Urol Moschini 14 651 2017 10.1038/nrurol.2017.125
BJU Int von Landenberg 119 656 2017 10.1111/bju.13780
Transl Androl Urol Klaile 5 692 2016 10.21037/tau.2016.06.13
Eur Urol Abufaraj 75 649 2019 10.1016/j.eururo.2018.11.052
Int J Mol Sci Pardo 21 6271 2020 10.3390/ijms21176271
Nat Commun Taber 11 4858 2020 10.1038/s41467-020-18640-0
J Urol Lotan 207 541 2022 10.1097/JU.0000000000002261
Eur Urol Sjödahl 81 523 2022 10.1016/j.eururo.2021.10.035
Eur Urol Pietzak 75 231 2019 10.1016/j.eururo.2018.09.002
Cancer Discov Van Allen 4 1140 2014 10.1158/2159-8290.CD-14-0623
JAMA Oncol Liu 2 1094 2016 10.1001/jamaoncol.2016.1056
Eur Urol Plimack 68 959 2015 10.1016/j.eururo.2015.07.009
Bladder Cancer Boxley 6 123 2020 10.3233/BLC-190266
Cancers (Basel) Hepburn 13 3903 2021 10.3390/cancers13153903
J Clin Oncol Lu 40 16 Suppl 4506 2022 10.1200/JCO.2022.40.16_suppl.4506
Clin Cancer Res Carthon 16 2861 2010 10.1158/1078-0432.CCR-10-0569
J Clin Oncol Necchi 36 3353 2018 10.1200/JCO.18.01148
Nat Med Powles 25 1706 2019 10.1038/s41591-019-0628-7
Nat Med van Dijk 26 1839 2020 10.1038/s41591-020-1085-z
Nat Rev Clin Oncol Galluzzi 17 725 2020 10.1038/s41571-020-0413-z
Front Immunol Opzoomer 10 1654 2019 10.3389/fimmu.2019.01654
J Clin Oncol Gupta 38 6 Suppl 439 2020 10.1200/JCO.2020.38.6_suppl.439
J Clin Oncol Hoimes 38 15 Suppl 5047 2020 10.1200/JCO.2020.38.15_suppl.5047
J Clin Oncol Funt 40 1312 2022 10.1200/JCO.21.01485
J Clin Oncol Cathomas 38 6 Suppl 499 2020 10.1200/JCO.2020.38.6_suppl.499
J Clin Oncol Rose 39 3140 2021 10.1200/JCO.21.01003
J Clin Oncol Kaimakliotis 38 15 Suppl 5019 2020 10.1200/JCO.2020.38.15_suppl.5019
Cancer Berg 125 1449 2019 10.1002/cncr.31952
J Clin Oncol Galsky 34 825 2016 10.1200/JCO.2015.64.1076
Clin Cancer Res Svatek 16 4461 2010 10.1158/1078-0432.CCR-10-0457
J Urol Skinner 145 459 1991 10.1016/S0022-5347(17)38368-4
J Clin Oncol Paz-Ares 28 18 Suppl LBA4518 2010 10.1200/jco.2010.28.18_suppl.lba4518
Eur Urol Leow 66 42 2014 10.1016/j.eururo.2013.08.033
N Engl J Med Bajorin 384 2102 2021 10.1056/NEJMoa2034442
Lancet Oncol Bellmunt 22 525 2021 10.1016/S1470-2045(21)00004-8
J Clin Oncol Grivas 40 6 Suppl TPS596 2022 10.1200/JCO.2022.40.6_suppl.TPS596
Front Oncol Roviello 12 912699 2022 10.3389/fonc.2022.912699
Cells Ungaro 11 803 2022 10.3390/cells11050803
J Hematol Oncol Criscitiello 14 20 2021 10.1186/s13045-021-01035-z
Appl Immunohistochem Mol Morphol Hoffman-Censits 29 619 2021 10.1097/PAI.0000000000000938
J Clin Oncol Rosenberg 37 2592 2019 10.1200/JCO.19.01140
N Engl J Med Powles 384 1125 2021 10.1056/NEJMoa2035807
J Clin Oncol Hoimes 40 6 Suppl TPS587 2022 10.1200/JCO.2022.40.6_suppl.TPS587
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.